Close Menu
    Trending
    • Abdominal Cancer Day 2025: ‘My Health, My Responsibility’ Emerges as a international Call for Awareness
    • Farha Naaz’s Comeback Isn’t About Films—It’s About Purpose: From Silver Screen to Street Safety
    • Siyaram Recycling Industries Ltd Reports Strong FY25 Results: Net Profit Surges 94% YoY
    • MindEscapes® Launches the Club Excellence Awards; Sets a Gold Standard for India’s Private Members Clubs
    • Aayush Wellness Expands into Preventive Healthcare with Smart Kiosks Stock Rises 80 Percent
    • Dr. Geeta Bora Honored with Global Leader Award at India-Russia Summit in Moscow
    • HubbleHox and SNDT Women’s University Collaborate to Empower the Next Generation of Educators
    • SEPC Ltd Announces Rs. 350 Crore Rights Issue; Bags Rs. 180 million Order from Bajaj Energy.
    Republic News TodayRepublic News Today
    • Business
    • Entertainment
    • Education
    • Health
    • Lifestyle
    • National
    • World
    • Press Release
    Republic News TodayRepublic News Today
    Home»Business»Dr. Deepak Shenoy, MD of Medec Dragon, honoured with Professorship at University of California, Berkeley
    Business

    Dr. Deepak Shenoy, MD of Medec Dragon, honoured with Professorship at University of California, Berkeley

    By May 10, 2022No Comments2 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi (India), May 10: Dr. Deepak Shenoy, MD of one of India’s fastest-growing pharmaceutical companies, Ms. Medec Dragon Pvt Limited, was conferred with the prestigious Title Honorary Professorship by The University of California- Berkeley.

    Dr Deepak Shenoy’s company Medec Dragon Pvt ssLimited, is a research-based pharmaceutical company. It has been growing exponentially because of the forward-looking approach of Dr. Shenoy with the risk-taking abilities in the current challenging situations at a time when the Pharma industry is facing a difficult task in pricing, clinical trials hurdles & regulatory approvals. The company exports to over 75 countries globally. The company provides anti-malarial, expectorant, emetic, CNS, anti-retro-viral, ace inhibitor, erectile dysfunction, animal health, anti-cancer, and diabetic APIs, as well as pain management products. It also offers formulations, such as anti-malarial finished dosages, animal health products, anti TB drug therapy products, expectorants/cold preparations/mucolytic, lozenges, and multivitamin syrups, analgesics, anti-obesity products, erectile dysfunction, and hormone replacement therapy products, and topicals.

    Dr. Shenoy is responsible for worldwide strategy and commercial growth at Medec Dragon Pvt Limited. Having vast knowledge about the field, Dr. Shenoy is bringing inventions that nobody has ever talked about. Medec Dragon’s 70 + formulation brands are being marketed in multiple countries, of which the dossier is in CTD format along with its respective bioequivalence. Their synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent rapport with their clients.

    University of California – Berkeley alumni, faculty, and researchers include more Nobel laureates, Turing Award winners, Fields Medalists, Wolf Prize winners, and MacArthur “Genius Grant” recipients than those of any other public university in the nation; they have also won 30 Pulitzer Prizes and 19 Academy Awards. The university has produced seven heads of state or government; six chief justices, including Chief Justice of the United States Earl Warren; 22 cabinet-level officials; 11 governors; and 25 living billionaires. It is also a leading producer of Fulbright Scholars, MacArthur Fellows, and Marshall Scholars. Berkeley alumni, widely recognized for their entrepreneurship, have founded numerous notable companies, including Apple, Tesla, Intel, eBay, SoftBank, AIG, Morgan Stanley, etc.

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleBLS International Services Ltd. Registers Operational Revenue of Rs 253.8 Crores for Q4 FY 2021-22, growth of 75.5% compared to Q4 FY 2020-21; Profit After Tax at Rs 35.2 Crores grew by 53.0% compared to Q4 FY 2020-21
    Next Article Dr. Ajit Kamath, MD of Arch Pharmalabs honoured with Professorship at University of California, Berkeley

    Related Posts

    Abdominal Cancer Day 2025: ‘My Health, My Responsibility’ Emerges as a international Call for Awareness

    May 21, 2025

    Siyaram Recycling Industries Ltd Reports Strong FY25 Results: Net Profit Surges 94% YoY

    May 21, 2025

    Smartags to Disrupt India’s DOOH Market with 1,000+ Screens and 40 Million Projected Consumer Reach

    May 21, 2025
    Recent Posts
    • Abdominal Cancer Day 2025: ‘My Health, My Responsibility’ Emerges as a international Call for Awareness
    • Farha Naaz’s Comeback Isn’t About Films—It’s About Purpose: From Silver Screen to Street Safety
    • Siyaram Recycling Industries Ltd Reports Strong FY25 Results: Net Profit Surges 94% YoY
    • MindEscapes® Launches the Club Excellence Awards; Sets a Gold Standard for India’s Private Members Clubs
    • Aayush Wellness Expands into Preventive Healthcare with Smart Kiosks Stock Rises 80 Percent
    • Dr. Geeta Bora Honored with Global Leader Award at India-Russia Summit in Moscow
    • HubbleHox and SNDT Women’s University Collaborate to Empower the Next Generation of Educators
    • SEPC Ltd Announces Rs. 350 Crore Rights Issue; Bags Rs. 180 million Order from Bajaj Energy.
    • Smartags to Disrupt India’s DOOH Market with 1,000+ Screens and 40 Million Projected Consumer Reach
    • A Consistent Global Trader and Fund Manager

    Type above and press Enter to search. Press Esc to cancel.